Cancer Health Treatment Update FDA Approves First-in-Class Immunotherapy for Uveal Melanoma Kimmtrak, the first approved T-cell receptor therapy, improved overall survival in a clinical trial. When Ovarian Cancer Returns, Surgery May Be a Good Choice For selected patients with access to skilled surgeons, surgery plus chemotherapy improves survival compared to chemotherapy alone. Antihistamines May Improve Response to Immunotherapy Allergy meds were linked to longer survival among cancer patients treated with immune checkpoint inhibitors. Advertisement Can mRNA Vaccines Help Treat Cancer? The success of the mRNA COVID-19 vaccines could help accelerate clinical research on vaccines to treat cancer. Is My Cloth Mask Good Enough? The 2022 Edition Public health officials are recommending that people upgrade from their cloth masks to higher-quality medical-grade masks. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Winter 2022 Check out our latest print edition! Newsfeed Colorectal Cancer Risk Is Higher Among Black and Latino Young Adults Can You Score Cheaper Meds via Mark Cuban’s Online Pharmacy? Major Progress In Lung Cancer Early Detection and Treatment Facilitates Drop in Overall Cancer Mortality Get Free COVID-19 Tests Sent to Your Home! Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer Newsfeed Colorectal Cancer Risk Is Higher Among Black and Latino Young Adults Can You Score Cheaper Meds via Mark Cuban’s Online Pharmacy? Major Progress In Lung Cancer Early Detection and Treatment Facilitates Drop in Overall Cancer Mortality Get Free COVID-19 Tests Sent to Your Home! Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: